Proxy Votes Now

Home › Funds › NYLIM VP FUNDS TRUST › NYLIM VP Balanced Portfolio

NYLIM VP Balanced Portfolio proxy voting record 2025-2026

Fund family: NYLIM VP FUNDS TRUST · Filed by NYLIM VP FUNDS TRUST (CIK 887340) · SEC series S000009437

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 779 with, 29 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 6 FOR, 23 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with NYLIM VP FUNDS TRUST as a whole

The same two figures as NYLIM VP FUNDS TRUST’s manager page (23,978 ballot items across 29 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsNYLIM VP FUNDS TRUSTItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)98.4%74395.1%20,920
Backed environmental and social shareholder proposals at US companiesn/a167.3%669

Where this fund voted differently from most NYLIM VP FUNDS TRUST funds

Each ballot item this fund voted is set against the votes of the other NYLIM VP FUNDS TRUST funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most NYLIM VP FUNDS TRUST funds on 7 items (2.6% of the 265 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost NYLIM VP FUNDS TRUST fundsMgmtResult
Pfizer Inc.2026-04-23Shareholder Adopt an Independent Chair PolicyForAGAINST — 4 of 4 NYLIM VP FUNDS TRUST fundsAgainstNot approved, 28.8% support
The Progressive Corporation2026-05-08Election of Directors: Lawton W. FittAgainstFOR — 4 of 4 NYLIM VP FUNDS TRUST fundsAgainstElected, 85.8% support
NetApp, Inc.2025-09-10To approve an amendment to NetApp's 2021 Equity Incentive Plan.ForAGAINST — 4 of 4 NYLIM VP FUNDS TRUST fundsForApproved, 68.0% support
Broadcom Inc.2026-04-20Advisory vote to approve the named executive officer compensation.ForAGAINST — 5 of 8 NYLIM VP FUNDS TRUST fundsForApproved, 66.4% support
KKR & Co. Inc.2026-05-21An amendment to the Existing Charter to establish stockholders' meetings as the sole mechanism for approval of matters on which holders of common stock are required or permitted to vote.ForAGAINST — 3 of 4 NYLIM VP FUNDS TRUST fundsFor—
Zoetis Inc.2026-05-20Shareholder Shareholder proposal to permit shareholder action by written consent.ForAGAINST — 3 of 5 NYLIM VP FUNDS TRUST fundsAgainst—
Chubb Limited2026-05-21Election of the Board of Directors: David H. SidwellForAGAINST — 2 of 3 NYLIM VP FUNDS TRUST fundsFor—

Download all 7 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 90.5% of this fund’s 808 such votes could be given a sector; the other 77 (9.5%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance22362.7%
Health Care1191310.9%
Technology8156.2%
Utilities7011.4%
Industrials5911.7%
Telecommunications3912.6%
Consumer Discretionary3712.7%
Consumer Staples2913.4%
Energy2700.0%
Real Estate2100.0%
Basic Materials1300.0%
Miscellaneous1300.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections5750
Audit-related610
Say-on-Pay560
Corporate Governance337
Capital Structure270
Compensation271
Shareholder Rights and Defenses145
Other Social Issues86
Diversity, Equity, and Inclusion44
Environment or Climate44

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
JPMorgan Chase & Co.May 19, 2026$9M174
Johnson & JohnsonApril 23, 2026$8M151
Merck & Co., Inc.May 26, 2026$6M183
Cisco Systems, Inc.December 16, 2025$6M131
Marathon Petroleum CorporationApril 29, 2026$6M80
UnitedHealth Group IncorporatedJune 1, 2026$6M121
Elevance Health, Inc.May 13, 2026$5M61
Pfizer Inc.April 23, 2026$4M161

Notable votes against management

MeetingCompanyProposalFundMgmt
May 19, 2026JPMorgan Chase & Co.Report on congruence of security, resiliency, and climate initiatives Shareholder proposalAgainstFor
May 19, 2026JPMorgan Chase & Co.Independent board chairman Shareholder proposalAgainstFor
April 23, 2026Johnson & JohnsonIndependent Board Chair Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor
December 16, 2025Cisco Systems, Inc.Stockholder Proposal - Approval to request the Board to conduct an evaluation and issue a report assessing how Cisco's Inclusion programs provide positive financial value to shareholders. Shareholder proposalAgainstFor
June 1, 2026UnitedHealth Group IncorporatedIf properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposalAgainstFor
May 13, 2026Elevance Health, Inc.Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups. Shareholder proposalAgainstFor
April 23, 2026Pfizer Inc.Adopt an Independent Chair Policy Shareholder proposalForAgainst
September 10, 2025NetApp, Inc.To approve a stockholder proposal regarding support for Special Shareholder Meeting Improvement. Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor

Search this fund’s votes by company

812 ballot items at 62 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, NYLIM VP Balanced Portfolio voted at 62 shareholder meetings of 60 companies, on 812 ballot items in all. Where management made a recommendation, the fund followed it on 96.4% of the items and voted against it 29 times. Its most frequent area of disagreement was corporate governance (7 of its votes against management). It voted on 29 shareholder proposals. It voted FOR the board's own proposals more often than NYLIM VP FUNDS TRUST's funds as a whole (98.4% against 95.1%). It voted differently from most NYLIM VP FUNDS TRUST funds on 7 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of NYLIM VP FUNDS TRUST’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.